Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangqi Guizhi Wuwu decoction for peripheral neuropathy in Parkinson's disease
ChiCTR2400090455Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Sep 2024
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of huang qi gui zhi wu wu tang in Parkinson's disease (PD) and peripheral neuropathy (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Peripheral nerve assessment. Started Sep 2024; status: completed.
02
Drugs
huang qi gui zhi wu wu tang
03
Conditions
Parkinson's disease (PD)peripheral neuropathy
Beyond the preview
Go deeper on ChiCTR2400090455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090455.